YOUR PARTNER
for a full Regulatory Affairs Service

Non-Clinical Phase

Having reached this stage your chances of reaching the market with your discovery compound have increased forty-fold*. (*Reference 1)

Still only 1 in 25 compounds will make it*. (*Reference 2) Acting on advice from your regulatory partner will increase your chances of success.

Would you like to know if you are on the right track with your pharmacology and toxicology studies?

Do you need carcinogenicity studies?

Will your non-clinical database be in compliance with ICH guidelines?

Using a pragmatic approach and good arguments, we could help you satisfy the regulators with a less costly and streamlined non-clinical programme.